- Home
- IMMP vs MPV Comparison
IMMP vs MPV Comparison
Compare IMMP & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- MPV
- Stock Information
- Founded
- IMMP 1987
- MPV 1988
- Country
- IMMP Australia
- MPV United States
- Employees
- IMMP N/A
- MPV N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- MPV Finance Companies
- Sector
- IMMP Health Care
- MPV Finance
- Exchange
- IMMP Nasdaq
- MPV Nasdaq
- Market Cap
- IMMP 221.2M
- MPV 213.6M
- IPO Year
- IMMP N/A
- MPV N/A
- Fundamental
- Price
- IMMP $1.72
- MPV $19.72
- Analyst Decision
- IMMP Buy
- MPV
- Analyst Count
- IMMP 1
- MPV 0
- Target Price
- IMMP $7.00
- MPV N/A
- AVG Volume (30 Days)
- IMMP 98.8K
- MPV 25.2K
- Earning Date
- IMMP 02-27-2025
- MPV 01-01-0001
- Dividend Yield
- IMMP N/A
- MPV 8.71%
- EPS Growth
- IMMP N/A
- MPV N/A
- EPS
- IMMP N/A
- MPV 1.71
- Revenue
- IMMP $3,019,249.00
- MPV N/A
- Revenue This Year
- IMMP $50.37
- MPV N/A
- Revenue Next Year
- IMMP N/A
- MPV N/A
- P/E Ratio
- IMMP N/A
- MPV $9.35
- Revenue Growth
- IMMP 24.11
- MPV N/A
- 52 Week Low
- IMMP $1.32
- MPV $11.18
- 52 Week High
- IMMP $2.72
- MPV $16.42
- Technical
- Relative Strength Index (RSI)
- IMMP 50.07
- MPV 63.21
- Support Level
- IMMP $1.53
- MPV $18.83
- Resistance Level
- IMMP $1.71
- MPV $20.35
- Average True Range (ATR)
- IMMP 0.07
- MPV 0.61
- MACD
- IMMP 0.01
- MPV 0.06
- Stochastic Oscillator
- IMMP 72.41
- MPV 66.49
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.